Novozymes A/S (CPH:NSIS.B)
428.90
-14.00 (-3.16%)
Sep 25, 2026, 3:40 PM CET
Novozymes Market Cap
Novozymes has a market cap or net worth of 206.35 billion as of September 25, 2026. Its market cap has increased by 15.89% in one year.
Market Cap
206.35B
Enterprise Value
226.99B
Revenue
32.13B
Ranking
n/a
PE Ratio
43.76
Stock Price
428.90
ChartMarket Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 206.35B, an increase of 1,358.51%. That is a compound annual growth rate of 11.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 206.35B | 8.67% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| A.P. Møller - Mærsk | 333.71B |
| Danske Bank | 298.71B |
| DSV A/S | 282.23B |
| Vestas Wind Systems | 195.75B |
| Ørsted | 179.33B |
| Genmab | 136.96B |
| Carlsberg | 121.34B |
| Coloplast | 94.48B |